Correlation Between Catalyst Pharmaceuticals and 970648AK7

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and 970648AK7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and 970648AK7 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and WTW 3875 15 SEP 49, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and 970648AK7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of 970648AK7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and 970648AK7.

Diversification Opportunities for Catalyst Pharmaceuticals and 970648AK7

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Catalyst and 970648AK7 is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and WTW 3875 15 SEP 49 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WTW 3875 15 and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with 970648AK7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WTW 3875 15 has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and 970648AK7 go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and 970648AK7

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 2.3 times more return on investment than 970648AK7. However, Catalyst Pharmaceuticals is 2.3 times more volatile than WTW 3875 15 SEP 49. It trades about 0.03 of its potential returns per unit of risk. WTW 3875 15 SEP 49 is currently generating about 0.0 per unit of risk. If you would invest  1,859  in Catalyst Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of  275.00  from holding Catalyst Pharmaceuticals or generate 14.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy59.11%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  WTW 3875 15 SEP 49

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
WTW 3875 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days WTW 3875 15 SEP 49 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for WTW 3875 15 SEP 49 investors.

Catalyst Pharmaceuticals and 970648AK7 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and 970648AK7

The main advantage of trading using opposite Catalyst Pharmaceuticals and 970648AK7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, 970648AK7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 970648AK7 will offset losses from the drop in 970648AK7's long position.
The idea behind Catalyst Pharmaceuticals and WTW 3875 15 SEP 49 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Technical Analysis
Check basic technical indicators and analysis based on most latest market data